Gandeeva Therapeutics
Latest round
- Series A
Last raised
- Jan 2022
Total raised
- $40M
Investors
- 6
About Gandeeva Therapeutics
Founded in 2021 and based in Vancouver, Canada, Gandeeva Therapeutics, Inc. operates as a biotechnology company that develops novel therapeutics through the use of cryogenic electron microscopy (cryo-EM) and machine learning. In 2021, the company was founded by Sriram Subramaniam, a medical expert that revolutionised the cryo-EM, also known as cryo-electron microscopy, method in clinical usage. He also has contribution to the study of HIV-1, influenza, and related viruses for vaccine development, and in focused ion beam technologies for cell and tissue imaging. Gandeeva develop pharmaceuticals via its AI-driven platforms -- SPOTLIGHT, HYPERFOCUS, CRYO-CADD -- all of which are engines that can help with drug develop process. SPOTLIGHT is the hit product that can visualise measure and capture protein-protein and protein-drug interactions to target disease-relevant proteins and influence their function.
Who invested in Gandeeva Therapeutics
6 investors across 1 round
See all investors in Gandeeva Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 13, 2022
Amount
$40M
Investors
Questions about Gandeeva Therapeutics
Who invested in Gandeeva Therapeutics?
Gandeeva Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gandeeva Therapeutics raised?
Gandeeva Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Gandeeva Therapeutics last raise money?
Gandeeva Therapeutics's most recent round on record is a Series A, in Jan 2022.
What does Gandeeva Therapeutics do?
Founded in 2021 and based in Vancouver, Canada, Gandeeva Therapeutics, Inc.
Where is Gandeeva Therapeutics headquartered?
Gandeeva Therapeutics is headquartered in Vancouver, Canada.
Which VCs invest in companies like Gandeeva Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Gandeeva Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Gandeeva Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.